Methotrexate exposure prior to and during pregnancy

Teratology

Volumn 49, Issue 2, 1994, Pages 79-81

  Donnenfeld, Alan E ^a,b,c   Pastuszak, Anne ^a,b,c   Noah, Jane Salkoff ^a,b,c   Schick, Betsy ^a,b,c   Rose, Nancy C ^a,b,c   Koren, Gideon ^a,b,c  

^a PENNSYLVANIA HOSPITAL   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DACTINOMYCIN; METHOTREXATE; PREDNISONE;

DRUG THERAPY; EMBRYO; HUMAN; LETTER; PREGNANCY; PRIORITY JOURNAL; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; ARTHRITIS, RHEUMATOID; DATA COLLECTION; FEMALE; FERTILIZATION; FOLIC ACID ANTAGONISTS; HUMAN; INFANT, NEWBORN; METHOTREXATE; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0028217035     PISSN: 00403709     EISSN: 10969926     Source Type: Journal    
DOI: 10.1002/tera.1420490202     Document Type: Letter

References (7)

1. Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation
2. Clinical teratology counseling and consultation case report: Low dose methotrexate exposure in the early weeks of pregnancy
3. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
4. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects
5. Further experience of vitamin supplementation for prevention of neural tube defect recurrences
6. Evaluation of the lemon and banana signs in one hundred thirty fetuses with open spina bifida